These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 30602023)

  • 1. High-Resolution Evolutionary Analysis of Within-Host Hepatitis C Virus Infection.
    Raghwani J; Wu CH; Ho CKY; De Jong M; Molenkamp R; Schinkel J; Pybus OG; Lythgoe KA
    J Infect Dis; 2019 May; 219(11):1722-1729. PubMed ID: 30602023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of Hepatitis C Virus (HCV) Envelope Diversification from Acute to Chronic Infection within a Sexually Transmitted HCV Cluster by Using Single-Molecule, Real-Time Sequencing.
    Ho CKY; Raghwani J; Koekkoek S; Liang RH; Van der Meer JTM; Van Der Valk M; De Jong M; Pybus OG; Schinkel J; Molenkamp R
    J Virol; 2017 Mar; 91(6):. PubMed ID: 28077634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vertical Transmission of Hepatitis C Virus: Variable Transmission Bottleneck and Evidence of Midgestation
    Fauteux-Daniel S; Larouche A; Calderon V; Boulais J; Béland C; Ransy DG; Boucher M; Lamarre V; Lapointe N; Boucoiran I; Le Campion A; Soudeyns H
    J Virol; 2017 Dec; 91(23):. PubMed ID: 28931691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification, molecular cloning, and analysis of full-length hepatitis C virus transmitted/founder genotypes 1, 3, and 4.
    Stoddard MB; Li H; Wang S; Saeed M; Andrus L; Ding W; Jiang X; Learn GH; von Schaewen M; Wen J; Goepfert PA; Hahn BH; Ploss A; Rice CM; Shaw GM
    mBio; 2015 Feb; 6(2):e02518. PubMed ID: 25714714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis C virus drug resistance and immune-driven adaptations: relevance to new antiviral therapy.
    Gaudieri S; Rauch A; Pfafferott K; Barnes E; Cheng W; McCaughan G; Shackel N; Jeffrey GP; Mollison L; Baker R; Furrer H; Günthard HF; Freitas E; Humphreys I; Klenerman P; Mallal S; James I; Roberts S; Nolan D; Lucas M
    Hepatology; 2009 Apr; 49(4):1069-82. PubMed ID: 19263475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phylogenetic Diversity in Core Region of Hepatitis C Virus Genotype 1a as a Factor Associated with Fibrosis Severity in HIV-1-Coinfected Patients.
    Parra M; Laufer N; Manrique JM; Jones LR; Quarleri J
    Biomed Res Int; 2017; 2017():1728456. PubMed ID: 29259976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vertical transmission of hepatitis C virus: a tale of multiple outcomes.
    Escobar-Gutiérrez A; Soudeyns H; Larouche A; Carpio-Pedroza JC; Martinez-Guarneros A; Vazquez-Chacon CA; Fonseca-Coronado S; Yamasaki LH; Ruiz-Tovar K; Cruz-Rivera M
    Infect Genet Evol; 2013 Dec; 20():465-70. PubMed ID: 24140559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phylogeographical Analysis Reveals Distinct Sources of HIV-1 and HCV Transmitted to Former Blood Donors in China.
    Du L; Wu J; Qian P; Xin R; Ni Y; Han R; Meng Z; Xia J
    AIDS Res Hum Retroviruses; 2017 Mar; 33(3):284-289. PubMed ID: 27473534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapy Implications of Hepatitis C Virus Genetic Diversity.
    Martinez MA; Franco S
    Viruses; 2020 Dec; 13(1):. PubMed ID: 33383891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombination in hepatitis C virus is not uncommon among people who inject drugs in Kolkata, India.
    Gupta D; Saha K; Biswas A; Firdaus R; Ghosh M; Sadhukhan PC
    Infect Genet Evol; 2017 Mar; 48():156-163. PubMed ID: 27923769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Previous failure of interferon-based therapy does not alter the frequency of HCV NS3 protease or NS5B polymerase inhibitor resistance-associated variants: longitudinal analysis in HCV/HIV co-infected patients.
    Sede MM; Laufer NL; Quarleri J
    Int J Antimicrob Agents; 2015 Aug; 46(2):219-24. PubMed ID: 26100213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intra-host evolution of multiple genotypes of hepatitis C virus in a chronically infected patient with HIV along a 13-year follow-up period.
    Culasso AC; Baré P; Aloisi N; Monzani MC; Corti M; Campos RH
    Virology; 2014 Jan; 449():317-27. PubMed ID: 24418566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis C virus NS3/4A quasispecies diversity in acute hepatitis C infection in HIV-1 co-infected patients.
    Nevot M; Boesecke C; Parera M; Andrés C; Franco S; Revollo B; Ingiliz P; Tural C; Clotet B; Rockstroh JK; Martinez MA;
    J Viral Hepat; 2014 Jun; 21(6):e19-28. PubMed ID: 24674023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using high-throughput sequencing for investigating intra-host hepatitis C evolution over long retrospective periods.
    Caporossi A; Kulkarni O; Blum M; Leroy V; Morand P; Larrat S; François O
    Infect Genet Evol; 2019 Jan; 67():136-144. PubMed ID: 30395998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evolution of within-host variants of the hepatitis C virus.
    Riaz N; Leung P; Bull RA; Lloyd AR; Rodrigo C
    Infect Genet Evol; 2022 Apr; 99():105242. PubMed ID: 35150893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extent of HCV NS3 protease variability and resistance-associated mutations assessed by next generation sequencing in HCV monoinfected and HIV/HCV coinfected patients.
    Bartolini B; Giombini E; Zaccaro P; Selleri M; Rozera G; Abbate I; Comandini UV; Ippolito G; Solmone M; Capobianchi MR
    Virus Res; 2013 Nov; 177(2):205-8. PubMed ID: 23954579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of the PKR-eIF2alpha phosphorylation homology domain (PePHD) of hepatitis C virus genotype 1 in HIV-coinfected patients by ultra-deep pyrosequencing and its relationship to responses to pegylated interferon-ribavirin treatment.
    Bolcic F; Sede M; Moretti F; Westergaard G; Vazquez M; Laufer N; Quarleri J
    Arch Virol; 2012 Apr; 157(4):703-11. PubMed ID: 22270759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High resolution sequencing of hepatitis C virus reveals limited intra-hepatic compartmentalization in end-stage liver disease.
    Hedegaard DL; Tully DC; Rowe IA; Reynolds GM; Bean DJ; Hu K; Davis C; Wilhelm A; Ogilvie CB; Power KA; Tarr AW; Kelly D; Allen TM; Balfe P; McKeating JA
    J Hepatol; 2017 Jan; 66(1):28-38. PubMed ID: 27531641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diversity and Evolution of HIV and HCV.
    Martinez MA
    Viruses; 2021 Apr; 13(4):. PubMed ID: 33918548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple Introduction and Naturally Occuring Drug Resistance of HCV among HIV-Infected Intravenous Drug Users in Yunnan: An Origin of China's HIV/HCV Epidemics.
    Chen M; Ma Y; Chen H; Luo H; Dai J; Song L; Yang C; Mei J; Yang L; Dong L; Jia M; Lu L
    PLoS One; 2015; 10(11):e0142543. PubMed ID: 26562015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.